Will LG Life Sciences & Sanofi’s lawsuit for ‘Zemiglo’ be prolonged?
A trial for the Zemiglo’s license between LG Life Sciences and Sanofi Aventis seems to be prolonged.
The Seoul Central District Court’s Civil Affairs Department 17 conducted the 3rd defense for the Sanofi Aventis’ damage claim suit against LG Life Sciences and Daewoong Pharmaceutical on the 18th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
